Arena Pharma (ARNA) Misses Q1 EPS by $1.79
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Total operating expenses: 29.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 29.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q1 EPS of $12.10, $1.79 worse than the analyst estimate of $13.89. Revenue for the quarter came in at $801.1 million versus the consensus estimate of $801.7 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
